Dr. Dewan Zeng, Innoforce CEO, has been invited to participate in the 9th Annual BFC-Sinolink HealthCare Conference in Shanghai on September 12. This event is dedicated to guiding Chinese biopharmaceutical companies in exploring business collaboration opportunities and facilitating efficient connections between them and investment firms.

Dr. Zeng will provide valuable insights on how the industry can ride the significant trend of expanding internationally, all the while mitigating risks and enhancing efficiency. Furthermore, she will engage in discussions with experts from the field to offer guidance for China's biomedical industry in venturing abroad in line with the prevailing trends of industry development.